Subscribe To
Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...
November 20, 2022, 6:30 pm
Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...
November 20, 2022, 6:30 pm
Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...
November 20, 2022, 6:30 pm
Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...
November 20, 2022, 6:30 pm
Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...
November 20, 2022, 6:30 pm
Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...
November 20, 2022, 6:30 pm
Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...
November 20, 2022, 6:30 pm
Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...
November 20, 2022, 6:30 pm
Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...
November 20, 2022, 6:30 pm
Viavi (viav) boosts production capacity with new az facility
The facility is expected to complement the strategic plan of Viavi (VIAV) to relocate its headquarters ...
November 18, 2022, 8:25 am
Browsi announces corporate rebrand reflecting expansion into video and becoming an all-in-one ad platform
Converging AI with groundbreaking video and display capabilities to provide full-stack advertising solutions for publishers Browsi Logo Browsi Logo NE...
November 17, 2022, 2:00 pm
Bux's uk 2021 revenue halved to £9.1m, losses deepen
Bux Financial Services Limited, the UK arm of BUX with ...
November 16, 2022, 11:41 am
Meta materials (mmat) stock climbs on new headquarters news
Meta Materials (NASDAQ: MMAT ) stock is on the move Tuesday as investors react to a couple of pieces of news about the company. To start with, there's...
November 15, 2022, 11:50 am
Alibaba's cainiao opens latam headquarters in brazil
The expansion comes as China's retail growth has slowed — Alibaba for the first time didn't release total sales for its Singles' Day shopping festiv...
November 13, 2022, 10:26 pm
Other firms take damage amid twitter chaos
It seems like Elon Musk strolled into the headquarters of Twitter holding a sink ages ago. In reality, ...
November 11, 2022, 7:18 pm
Sword health launches move, a first of its kind movement health solution that will empower members to start moving, stay moving, and live pain-free
Company expands its efforts in solving pain by pioneering a new solution that combines the clinical focus of physical therapy and the holistic approac...
November 10, 2022, 1:29 pm
Vicinity motor reveals positive construction update on its washington state manufacturing facility
Vicinity Motor Corp. (TSX-V:VMC) has provided an update on the construction of its new manufacturing facility in Ferndale, Washington, saying it antic...
November 9, 2022, 9:33 am
Orix corporation (ix) q2 2023 earnings call transcript
ORIX Corporation (NYSE:IX ) Q2 2023 Earnings Conference Call November 7, 2022 2:30 AM ET Company Participants Hitomaro Yano - Executive Officer, Head ...
November 7, 2022, 9:10 am
China evergrande lenders appoint receiver to seize hong kong headquarters: sources
Creditors of Chinese real estate developer Evergrande appoint a receiver to take the company's 26-story China Evergrande Centre in Hong Kong....
September 8, 2022, 4:40 pm
Evergrande crisis deepens as lender seizes headquarters - ft
China Evergrande Group's Hong Kong headquarters has been seized by a lender after the struggling Chines...
September 8, 2022, 6:40 am